Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 2.61% is 47% below its 5-year average of 4.95%, near the low end of its 5-year range (-1.10%–23.41%).
3.59% below its 12-month average of 2.71%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.53%.
OPERATING MARGIN
2.61%
OPERATING MARGIN AVG TTM
2.71%
OPERATING MARGIN AVG 3Y
4.19%
OPERATING MARGIN AVG 5Y
4.95%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-3.59%
CURRENT VS 3Y AVG
-37.66%
CURRENT VS 5Y AVG
-47.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Astrana Health, Inc.
Market Cap
$1.83B
Operating Margin
2.61%
TTM Avg
2.71%
3Y Avg
4.19%
5Y Avg
4.95%
Market Cap
$1.87B
Operating Margin
-873.87%
TTM Avg
-1020.17%
3Y Avg
-1557.98%
5Y Avg
-1038.65%
Market Cap
$1.78B
Operating Margin
-737.04%
TTM Avg
-849.82%
3Y Avg
-849.82%
5Y Avg
-849.82%
Market Cap
$1.78B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$1.89B
Operating Margin
-1.12%
TTM Avg
-4.89%
3Y Avg
-11.52%
5Y Avg
-13.12%
Market Cap
$1.76B
Operating Margin
1.20%
TTM Avg
-1.69%
3Y Avg
-4.84%
5Y Avg
-5.86%
Market Cap
$1.71B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.95B
Operating Margin
-4454.21%
TTM Avg
-3427.90%
3Y Avg
-2683.37%
5Y Avg
-2097.52%
Market Cap
$1.96B
Operating Margin
-18.48%
TTM Avg
-24.30%
3Y Avg
-28.12%
5Y Avg
-27.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Astrana Health, Inc. (ASTH) | $1.83B | 2.61% | 2.71% | 4.19% | 4.95% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -873.87% | -1020.17% | -1557.98% | -1038.65% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -737.04% | -849.82% | -849.82% | -849.82% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -651.67% | -787.38% | -968.58% | -820.03% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -1.12% | -4.89% | -11.52% | -13.12% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.20% | -1.69% | -4.84% | -5.86% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 11.69% | -8.16% | -10.59% | -4.68% |
| Absci Corporation (ABSI)vs › | $1.95B | -4454.21% | -3427.90% | -2683.37% | -2097.52% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -18.48% | -24.30% | -28.12% | -27.55% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -3.49% | -3.57% | -5.95% | -5.03% |
Gross Margin
9.2%
Operating Margin
2.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 3.53% |
| 2026-03-31 | 2.96% |
| 2025-12-31 | 1.94% |
| 2025-09-30 | 2.01% |
| 2025-06-30 | 3.11% |
| 2025-03-31 | 3.32% |
| 2024-12-31 | 0.11% |
| 2024-09-30 | 5.94% |
| 2024-06-30 | 6.18% |
| 2024-03-31 | 7.45% |
| 2023-12-31 | -1.10% |
| 2023-09-30 | 11.23% |
| 2023-06-30 | 7.76% |
| 2023-03-31 | 6.63% |
| 2022-12-31 | 4.28% |
| 2022-09-30 | 15.80% |
| 2022-06-30 | 5.70% |
| 2022-03-31 | 9.96% |
| 2021-12-31 | 1.15% |
| 2021-09-30 | 23.41% |
| 2021-06-30 | 11.95% |
